7,186 press releases indexed under healthcare.
SOUTH JORDAN, Utah, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management is scheduled to participate in the following upcoming investor conferences:
Dr. Helen Wall’s new book, Menopause and ADHD: How to Navigate Hormone Flux and Neurodivergence, was launched to a full house at Book, Bean and Ice Cream in Kirkham, Preston. An afternoon that moved many attendees to tears and sparked honest, overdue conversations about women’s health. [PR.com]
(PR-inside.com) As demand for cosmetic surgery rises, PREEVŪ Plastic proves consultation qualification best happens before the patient ever sits down with the surgeon. CHATTANOOGA, TN / ACCESS Newswire / September 4, 2026 / Cosmetic surgery is growing again. The American Society of Plastic Surgeons reported this week that cosmetic surgical procedures increased 7% in 2025, with breast augmentation rising 11% and liposuction remaining one of the most commonly performed cosmetic procedures in the country. At the same time, 82% of ASPS member surgeons said they had received consultation requests related to GLP-1 weight loss, another sign that the profile of the modern ..
(PR-inside.com) Follow-Up to August 31 Announcement: First Cohort Process Is Now Open for Real-World Image Testing MESA, AZ / ACCESS Newswire / September 4, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced that volunteer intake is now active for the first human-submitted image cohort supporting MDCE Melanoma Scan Beta - advancing the initiative first announced on August 31, 2026. On August 31, the Company said it was seeking its first volunteers in order to move beyond testing and training based solely on established public cancer imaging datasets, including HAM10000, ISIC Archive collections, and TCIA melanoma cohorts. That announcement marked the start of ..
Follow-Up to August 31 Announcement: First Cohort Process Is Now Open for Real-World Image Testing
Expands Nanox’s growing U.S. distribution network with a leading New England-based medical imaging provider
Adds gildeuretinol (ALK-001), a differentiated Phase 3 oral investigational medicine designed to target the underlying biology of Stargardt’s disease, a potentially blinding disease with no FDA-approved therapy
As Canada's New Brunswick province commits $4 million to expand its Nursing Home Without Walls program — and nursing home waitlists swell to nearly 1,000 patients — the conversation around aging in place has shifted from preference to urgent necessity. SonderCare, a premium home hospital bed manufacturer with over 25 years of healthcare expertise, says the policy momentum is meaningful, but its impact depends entirely [PR.com]
Consumer Product Events Reveals Its Favorite Beauty + Wellness Brands Worth Buying Now, Spotlighting the Products Winning Over Today's Selective, Health-Conscious Shopper MALIBU, Calif., Sept. 4, 2026 /PRNewswire/ -- As U.S. beauty sales climb 7% and the industry's $56 billion "feel-good...
(PR-inside.com) Jaguar remains sharply focused on its ongoing global development program for oral crofelemer as adjunctive therapy to parenteral support (PS) for pediatric and adult rare IF diseases, including microvillus inclusion disease (MVID) Company plans to file NDA for crofelemer for MVID in mid-2027 to obtain FDA approval SAN FRANCISCO, CA / ACCESS Newswire / September 4, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that Jaguar family company Napo Pharmaceuticals (Napo) is providing the company's novel crofelemer powder for oral solution for treatment of intestinal failure (IF) in an infant patient due to congenital sodium diarrhea (CSD), which is caused by ..
Jaguar remains sharply focused on its ongoing global development program for oral crofelemer as adjunctive therapy to parenteral support (PS) for pediatric and adult rare IF diseases, including microvillus inclusion disease (MVID) Company plans to file NDA for crofelemer for MVID in mid-2027 to obtain FDA approval
In this free webinar, learn how hybrid monitoring can strengthen oversight and study execution in in vitro diagnostic (IVD) clinical studies. The featured speakers will discuss how sponsor delegation, centralized oversight and on-site monitoring can support regulatory compliance, quality...